Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Short-term Investments (2020 - 2025)

Cellebrite DI (CLBT) has 5 years of Short-term Investments data on record, last reported at $161.0 million in Q4 2025.

  • For Q4 2025, Short-term Investments rose 4.75% year-over-year to $161.0 million; the TTM value through Dec 2025 reached $161.0 million, up 4.75%, while the annual FY2025 figure was $161.0 million, 4.75% up from the prior year.
  • Short-term Investments reached $161.0 million in Q4 2025 per CLBT's latest filing, up from $153.7 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $161.0 million in Q4 2025 and bottomed at $38.7 million in Q4 2023.
  • Average Short-term Investments over 4 years is $99.5 million, with a median of $99.2 million recorded in 2022.
  • Peak YoY movement for Short-term Investments: decreased 13.33% in 2023, then skyrocketed 297.35% in 2024.
  • A 4-year view of Short-term Investments shows it stood at $44.6 million in 2022, then fell by 13.33% to $38.7 million in 2023, then surged by 297.35% to $153.7 million in 2024, then increased by 4.75% to $161.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Short-term Investments were $161.0 million in Q4 2025, $153.7 million in Q4 2024, and $38.7 million in Q4 2023.